Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002771
Filing Date
2023-02-17
Accepted
2023-02-17 16:29:17
Documents
1
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02172023_090226.html 4  
1 form4-02172023_090226.xml 4 4070
  Complete submission text file 0001415889-23-002771.txt   5574
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address
Jansen Valerie Malyvanh (Reporting) CIK: 0001889716 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40523 | Film No.: 23643062